Correction
DKP/TRAM(N = 152) | DKP (N = 151) | TRAM (N = 150) | Placebo (N = 153) | ||
---|---|---|---|---|---|
TOTPAR2
| Responder, n (%) | 91 (60) | 69 (46) | 58 (39) | 50 (33) |
Non-Responder, n (%) | 60 (40) | 82 (54) | 91 (61) | 103 (67) | |
Treatment comparisons p-value | |||||
DKP/TRAM vs. DKP | 0.011 | ||||
DKP/TRAM vs. TRAM | <0.001 | ||||
DKP vs. Placebo | 0.020 | ||||
TRAM vs. Placebo | 0.258 | ||||
TOTPAR4
| Responder, n (%) | 99 (65) | 80 (53) | 65 (43) | 49 (32) |
Non-Responder, n (%) | 52 (34) | 71 (47) | 84 (56) | 104 (68) | |
Treatment comparisons p-value | |||||
DKP/TRAM vs. DKP | 0.026 | ||||
DKP/TRAM vs. TRAM | <0.001 | ||||
DKP vs. Placebo | <0.001 | ||||
TRAM vs. Placebo | 0.038 | ||||
TOTPAR6
| Responder, n (%) | 105 (69) | 72 (48) | 64 (43) | 49 (32) |
Non-Responder, n (%) | 46 (30) | 79 (52) | 85 (57) | 104 (68) | |
Treatment comparisons p-value | |||||
DKP/TRAM vs. DKP | <0.001 | ||||
DKP/TRAM vs. TRAM | <0.001 | ||||
DKP vs. Placebo | 0.005 | ||||
TRAM vs. Placebo | 0.050 | ||||
TOTPAR8
| Responder, n (%) | 100 (66) | 72 (48) | 66 (44) | 47 (31) |
Non-Responder, n (%) | 51 (34) | 79 (52) | 83 (55) | 106 (69) | |
Treatment comparisons p-value | |||||
DKP/TRAM vs. DKP | 0.001 | ||||
DKP/TRAM vs. TRAM | <0.001 | ||||
DKP vs. Placebo | 0.002 | ||||
TRAM vs. Placebo | 0.015 |